{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:39:23Z","timestamp":1791441563328,"version":"4.3.3"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jcyt.2023.05.015","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T19:13:11Z","timestamp":1687633991000},"page":"1212-1219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4998-9078","authenticated-orcid":false,"given":"Yosuke","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5188-9063","authenticated-orcid":false,"given":"Hiroyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-6680","authenticated-orcid":false,"given":"Nobuhiro","family":"Hiramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2635-3395","authenticated-orcid":false,"given":"Shinichi","family":"Kako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-6909","authenticated-orcid":false,"given":"Akinori","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hangaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9315","authenticated-orcid":false,"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcyt.2023.05.015_bib0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3324\/haematol.2017.174573","article-title":"From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives","volume":"103","author":"Gay","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jcyt.2023.05.015_bib0002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2007-01-041871","article-title":"How I treat patients with diffuse large B-cell lymphoma","volume":"110","author":"Armitage","year":"2007","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jcyt.2023.05.015_bib0003","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jcyt.2023.05.015_bib0004","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00277-020-04112-4","article-title":"Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma","volume":"99","author":"Nagayama","year":"2020","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.jcyt.2023.05.015_bib0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hon.2427","article-title":"Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome","volume":"36","author":"Akahoshi","year":"2018","journal-title":"Hematol Oncol"},{"issue":"7","key":"10.1016\/j.jcyt.2023.05.015_bib0006","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/bmt.2010.218","article-title":"Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival","volume":"46","author":"Ram\u00edrez","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2023.05.015_bib0007","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bjh.13118","article-title":"Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia","volume":"168","author":"Wetzel","year":"2015","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.jcyt.2023.05.015_bib0008","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00277-014-2112-2","article-title":"Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre","volume":"93","author":"Bai","year":"2014","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.jcyt.2023.05.015_bib0009","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1200\/JCO.2000.18.6.1360","article-title":"Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy","volume":"18","author":"Siena","year":"2000","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2023.05.015_bib0010","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/blood.V85.2.588.588","article-title":"Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients","volume":"85","author":"Tricot","year":"1995","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jcyt.2023.05.015_bib0011","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbmt.2010.11.021","article-title":"Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"17","author":"Stiff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2023.05.015_bib0012","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1083-8791(03)00232-5","article-title":"High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia","volume":"9","author":"Gunn","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2023.05.015_bib0013","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","article-title":"Factors that influence collection and engraftment of autologous peripheral-blood stem cells","volume":"13","author":"Bensinger","year":"1995","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jcyt.2023.05.015_bib0014","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bmt.1703575","article-title":"Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation","volume":"29","author":"Allan","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2023.05.015_bib0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bmt.1705818","article-title":"Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation","volume":"40","author":"Sartor","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2023.05.015_bib0016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1532\/IJH97.06239","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int J Hematol"},{"issue":"18","key":"10.1016\/j.jcyt.2023.05.015_bib0017","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","article-title":"Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1","volume":"117","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2023.05.015_bib0018","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.jcyt.2023.05.015_bib0019","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jcyt.2023.05.015_bib0020","first-page":"1860","article-title":"Report of the Committee on Hodgkin's Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.jcyt.2023.05.015_bib0021","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1111\/cas.15163","article-title":"Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine","volume":"112","author":"Shimazu","year":"2021","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.jcyt.2023.05.015_bib0022","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2023.05.015_bib0023","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00277-016-2740-9","article-title":"Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan","volume":"95","author":"Sugimoto","year":"2016","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.jcyt.2023.05.015_bib0024","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/bmt.2009.165","article-title":"Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group","volume":"45","author":"Numata","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jcyt.2023.05.015_bib0025","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/1097-0142(19910401)67:7<1830::AID-CNCR2820670703>3.0.CO;2-E","article-title":"Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia\/lymphoma with high-risk features","volume":"67","author":"Takaue","year":"1991","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jcyt.2023.05.015_bib0026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02986620","article-title":"Pilot phase I\/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma","volume":"77","author":"Ogura","year":"2003","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.jcyt.2023.05.015_bib0027","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbmt.2014.04.015","article-title":"Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Kong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2023.05.015_bib0028","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbmt.2013.07.014","article-title":"Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Kong","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2023.05.015_bib0029","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2003-07-2340","article-title":"Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines","volume":"103","author":"Nefedova","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcyt.2023.05.015_bib0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bmt.1704555","article-title":"Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy","volume":"34","author":"Kumar","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.05.015_bib0031","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.0105-2896.2005.00323.x","article-title":"The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma","volume":"208","author":"Ehrlich","year":"2005","journal-title":"Immunol Rev"},{"issue":"26","key":"10.1016\/j.jcyt.2023.05.015_bib0032","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.jcyt.2023.05.015_bib0033","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jcyt.2023.05.015_bib0034","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2009-07-232801","article-title":"IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms","volume":"115","author":"De Bruyne","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jcyt.2023.05.015_bib0035","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2004-07-2909","article-title":"The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications","volume":"105","author":"Podar","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jcyt.2023.05.015_bib0036","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41375-018-0061-9","article-title":"Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?","volume":"32","author":"Xu","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jcyt.2023.05.015_bib0037","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7","article-title":"Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells","volume":"176","author":"Majumdar","year":"1998","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.jcyt.2023.05.015_bib0038","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0301-472X(03)00042-0","article-title":"Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD\/SCID mice","volume":"31","author":"Angelopoulou","year":"2003","journal-title":"Exp Hematol"},{"issue":"12","key":"10.1016\/j.jcyt.2023.05.015_bib0039","doi-asserted-by":"crossref","first-page":"e8359","DOI":"10.1371\/journal.pone.0008359","article-title":"Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis","volume":"4","author":"Pallotta","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jcyt.2023.05.015_bib0040","doi-asserted-by":"crossref","first-page":"e59756","DOI":"10.1371\/journal.pone.0059756","article-title":"Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells","volume":"8","author":"Andr\u00e9","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jcyt.2023.05.015_bib0041","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00005-008-0022-5","article-title":"Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells","volume":"56","author":"Zdzisi\u0144ska","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"11","key":"10.1016\/j.jcyt.2023.05.015_bib0042","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1002\/ijc.31619","article-title":"The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy-induced toxicity","volume":"143","author":"R\u00fchle","year":"2018","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jcyt.2023.05.015_bib0043","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bmt.1704826","article-title":"Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis","volume":"35","author":"Oran","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jcyt.2023.05.015_bib0044","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/j.clml.2019.04.002","article-title":"Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients","volume":"19","author":"Lazarow","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"10.1016\/j.jcyt.2023.05.015_bib0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamaoncol.2018.6278","article-title":"Maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation: a consensus project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT","volume":"5","author":"Kanate","year":"2019","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.jcyt.2023.05.015_bib0046","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1200\/JCO.18.00685","article-title":"Autologous transplantation, consolidation, and maintenance therapy in multiple myeloma: results of the BMT CTN 0702 Trial","volume":"37","author":"Stadtmauer","year":"2019","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jcyt.2023.05.015_bib0047","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMoa1114083","article-title":"Lenalidomide after stem-cell transplantation for multiple myeloma","volume":"366","author":"McCarthy","year":"2012","journal-title":"N Engl J Med"},{"issue":"29","key":"10.1016\/j.jcyt.2023.05.015_bib0048","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1200\/JCO.2017.72.6679","article-title":"Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis","volume":"35","author":"McCarthy","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jcyt.2023.05.015_bib0049","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(18)30687-9","article-title":"Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Jackson","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923009611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923009611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:50:41Z","timestamp":1761443441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923009611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1465324923009611"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.05.015","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}